Cardiovascular morbidity and mortality associated with the metabolic syndrome.
Document Actions
The cardiovascular morbidity and mortality associated with the presence of the clinical features of Metabolic Syndrome were quantified in a large cohort of men and women from the Botnia Study. It was reported that the risk of cardiovascular morbidity and mortality was respectively increased by 3-fold (p<0.001) and 1.8-fold (p=0.002) in subjects meeting the clinical criteria of the Metabolic Syndrome emphasizing the relevance of assessing in clinical practice, the presence of the Metabolic Syndrome.
Authors:Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L.
PMID/ref:Diabetes Care 24:683-689, 2001.
